Current medical treatment for the exacerbation of chronic heart failure resulting in hospitalization.
Jain
Parag
P
Northwestern University, Feinberg School of Medicine, Chicago, Ill 60611, USA.
Massie
Barry M
BM
Gattis
Wendy A
WA
Klein
Livin
L
Gheorghiade
Mihai
M
D000368:Aged; D004232:Diuretics / Q000627:therapeutic use; D004280:Dobutamine / Q000627:therapeutic use; D015773:Enalaprilat / Q000627:therapeutic use; D005260:Female; D006333:Heart Failure / Q000188:drug therapy* / Q000503:physiopathology; D006439:Hemodynamics; D006760:Hospitalization; D006801:Humans; D006835:Hydrazones / Q000627:therapeutic use; D007275:Injections, Intravenous; D008297:Male; D020105:Milrinone / Q000627:therapeutic use; D045283:Natriuretic Agents / Q000627:therapeutic use; D020097:Natriuretic Peptide, Brain; D009599:Nitroprusside / Q000627:therapeutic use; D011669:Pulmonary Wedge Pressure / Q000187:drug effects / Q000502:physiology; D011724:Pyridazines / Q000627:therapeutic use; D012076:Renal Agents / Q000627:therapeutic use; D000077464:Simendan; D014665:Vasodilator Agents / Q000627:therapeutic use
D004232:Diuretics; D006835:Hydrazones; D045283:Natriuretic Agents; D011724:Pyridazines; D012076:Renal Agents; D014665:Vasodilator Agents; D020097:Natriuretic Peptide, Brain; D009599:Nitroprusside; D000077464:Simendan; D004280:Dobutamine; D015773:Enalaprilat; D020105:Milrinone